ArticleThe Lancet. Oncology2017
Continued disappointments with targeted agents in first-line therapy of advanced gastric cancers.
Daniel H Ahn et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleThe Lancet. Oncology2017
Daniel H Ahn et al.PubMed ↗Publisher ↗
No numbers read from the abstract.